Endoscopic resolution and recurrence of gastric antral vascular ectasia after serial treatment with argon plasma coagulation

Table 1 Demographic features of patients with symptomatic gastric antral vascular ectasia n (%)

	Patients with cirrhosis (n = 16)	Patients without cirrhosis (n = 4)	P value
Median age (range) in years	59.5 (42-74)	62.5 (53-73)	0.51
Males	9 (56.3)	1 (25)	0.58
Caucasians	16 (100)	4 (100)	-
Indication for initial EGD			-
Upper gastrointestinal tract bleeding	7 (43.7)	2 (50)
Iron deficiency anemia	5 (31.3)	1 (25)
Esophageal varices screening or surveillance	4 (25)	-
Follow up of arteriovascular malformations	-	1 (25)
Median number of APC sessions (range)	2 (1-7)	2.5 (1-6)	0.66
Endoscopic resolution of GAVE	8 (50)	0	0.12
Recurrence of GAVE	2/8 (25%)	-	-

APC: Argon plasma coagulation; EGD: Esophagogastroduodenoscopy; GAVE: Gastric antral vascular ectasia.